Viking Therapeutics Balance Sheet (2014-2026) | VKTX

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
11.26M26.37M178.60M152.69M29.41M36.63M18.36M69.52M37.19M55.52M195.58M43.91M50.35M26.68M37.94M33.88M100.38M165.81M118.12M125.75M
Prepaid Assets (Quarter)
0.92M0.62M0.39M1.09M0.96M3.41M3.93M0.96M0.67M2.52M0.64M0.14M1.73M1.13M0.86M2.81M2.24M1.81M1.22M0.94M
Current Assets (Quarter)
224.28M210.53M193.30M179.86M165.15M167.04M149.47M399.37M381.30M367.23M966.34M945.72M936.65M907.22M866.02M827.02M738.70M715.60M608.21M517.56M
Non-Current Assets
Other Non-Current Assets (Quarter)
0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.05M0.05M0.05M0.05M0.05M0.05M0.03M0.21M
Non-Current Assets (Quarter)
0.19M0.13M1.73M1.65M1.54M1.49M1.43M1.32M1.36M1.26M1.18M1.11M1.24M1.10M0.97M0.83M0.71M0.13M0.03M4.33M
Assets (Quarter)
224.47M210.66M195.03M181.51M166.68M168.53M150.90M400.69M382.66M368.49M967.52M946.84M937.89M908.32M866.99M827.85M739.41M715.73M608.24M521.90M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
2.85M1.44M3.12M6.10M3.14M8.53M3.80M5.61M5.71M7.51M5.22M11.09M0.25M9.81M7.70M5.49M4.41M53.25M67.18M69.01M
Notes Payables (Quarter)
Payables (Quarter)
2.85M1.44M3.12M6.10M3.14M8.53M3.80M5.61M5.71M7.51M5.22M11.09M0.25M9.81M7.70M5.49M4.41M53.25M67.18M69.01M
Accumulated Expenses (Quarter)
Other Accumulated Expenses (Quarter)
8.39M7.30M8.00M8.52M10.62M13.11M11.54M7.55M7.38M11.30M27.22M13.67M24.95M17.11M11.37M26.02M21.22M23.28M39.14M40.48M
Current Leases (Quarter)
0.12M0.03M0.15M0.24M0.30M0.30M0.31M0.31M0.32M0.32M0.33M0.33M0.48M0.49M0.50M0.47M0.44M0.14M0.16M
Total Current Liabilities (Quarter)
11.35M8.78M11.27M14.86M14.06M21.95M15.65M13.48M13.40M19.14M32.77M25.09M25.68M27.41M19.57M31.98M26.07M76.67M106.33M109.66M
Non-Current Liabilities
Non-Current Debt (Quarter)
Convertible Debt (Quarter)
Non-Current Deffered Revenue (Quarter)
Operating Leases (Quarter)
1.49M1.41M1.34M1.26M1.18M1.10M1.02M0.94M0.85M0.77M0.76M0.63M0.50M0.41M0.32M3.92M
Total Non-Current Liabilities (Quarter)
1.49M1.41M1.34M1.26M1.18M1.10M1.02M0.94M0.85M0.77M0.76M0.63M0.50M0.41M0.32M3.92M
Total Liabilities (Quarter)
11.35M8.78M12.76M16.28M15.40M23.21M16.83M14.58M14.42M20.07M33.63M25.86M26.44M28.04M20.07M32.39M26.39M76.67M106.33M113.58M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)
213.12M201.88M182.27M165.23M151.28M145.32M134.06M386.12M368.24M348.42M933.89M920.98M911.45M880.28M846.92M795.46M713.03M639.06M501.92M408.32M
Liabilities and Shareholders Equity (Quarter)
224.47M210.66M195.03M181.51M166.68M168.53M150.90M400.69M382.66M368.49M967.52M946.84M937.89M908.32M866.99M827.85M739.41M715.73M608.24M521.90M
Treasury Shares (Quarter)
0.96M1.03M1.77M2.19M2.19M1.87M2.70M2.86M2.86M2.86M2.83M2.83M2.54M2.54M2.30M2.30M2.22M2.11M1.82M1.81M
Retained Earnings (Quarter)
-210.83M-223.18M-239.28M-256.72M-272.49M-292.05M-311.58M-330.81M-353.34M-377.94M-405.30M-427.55M-452.49M-487.91M-533.54M-599.10M-689.88M-847.55M-1005.87M-1133.89M